CTOs on the Move

Cortex Group

www.remoterep.com

 
Cortex Group, Inc. is a Guelph, ON-based company in the Software and Internet sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Drizzlex

DrizzleX is a pioneering smart water metering solution that enables significant water conservation in residential buildings that lack individual apartment meters. They provide a water management Software as a Service (SAAS) that empowers users to smart...

CS Disco

As the leading provider of software as a service solutions developed by lawyers for lawyers, DISCO is reinventing legal technology to automate and simplify complex and error-prone tasks that distract from practicing law. DISCO has been embraced by more than 400 law firms, including 50 of the top AmLaw 200, as their first choice for innovative technologies that enhance the practice of law to help secure justice and win cases.

Figured

Figured is a farm financial management software that provides online livestock, crop, and production tracking, farm budgeting and forecasting tools that work hand in hand with Xero.

PLATO Learning

As a leading provider of education technology solutions, PLATO Learning offers innovative, high-value online curricula and assessments.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.